tiprankstipranks
Trending News
More News >
HOYA CORPORATION (HOCPY)
OTHER OTC:HOCPY

HOYA (HOCPY) AI Stock Analysis

Compare
35 Followers

Top Page

HOCPY

HOYA

(OTC:HOCPY)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
$159.00
▲(3.72% Upside)
HOYA's strong financial performance is the most significant factor driving its overall score, reflecting solid profitability and a stable balance sheet. However, the technical analysis presents mixed signals, with short-term bearish momentum offset by longer-term bullish trends. The valuation suggests the stock is relatively expensive, which may constrain future growth. The absence of notable earnings call insights or corporate events means these factors do not influence the score.
Positive Factors
Revenue Growth
HOYA's robust revenue growth and high margins indicate effective cost management and strong market demand, supporting long-term expansion.
Balance Sheet Health
A low debt-to-equity ratio reflects prudent financial leverage, enhancing financial stability and enabling strategic investments.
Cash Flow Generation
Consistent free cash flow growth ensures liquidity and supports reinvestment in business operations, fostering sustainable growth.
Negative Factors
Operational Efficiency
Operational inefficiencies could hinder profitability and growth, requiring management focus to optimize processes and cost structures.
EBIT and EBITDA Margin Fluctuations
Fluctuating margins may indicate volatility in cost control or pricing power, potentially impacting future profitability if not addressed.
Valuation Constraints
High valuation may limit upside potential, as investors may seek more attractively priced alternatives, affecting stock performance.

HOYA (HOCPY) vs. SPDR S&P 500 ETF (SPY)

HOYA Business Overview & Revenue Model

Company DescriptionHOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHOYA generates revenue through multiple key streams. The Eye Care segment contributes a significant portion of its income through the sale of prescription lenses, which are marketed to both consumers and optical retailers worldwide. This segment benefits from a growing demand for corrective eyewear due to increasing vision-related issues globally. In the Healthcare segment, revenue is derived from the sale of medical devices such as endoscopes and surgical instruments, which are utilized in various medical procedures. Additionally, HOYA earns revenue from the production of semiconductor materials, which are essential for the electronics industry. The company has established partnerships with major optical retailers and healthcare providers, enhancing its market reach and contributing to its consistent earnings. Overall, HOYA's diverse product offerings and strategic collaborations play a crucial role in its financial performance.

HOYA Financial Statement Overview

Summary
HOYA presents a robust financial profile with strong profitability, a solid balance sheet, and healthy cash flow generation. The company is well-positioned for growth with efficient operations and prudent financial management. While there are minor areas for improvement, particularly in operational efficiency, the overall financial health is commendable.
Income Statement
85
Very Positive
HOYA demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management and strong pricing power. The company shows robust revenue growth, particularly in the TTM period, reflecting successful business expansion. However, slight fluctuations in EBIT and EBITDA margins suggest potential areas for operational improvement.
Balance Sheet
88
Very Positive
HOYA maintains a solid balance sheet with a low debt-to-equity ratio, indicating prudent financial leverage and strong equity position. The return on equity is impressive, showcasing effective management of shareholder funds. The equity ratio is healthy, reflecting a stable financial structure with substantial asset backing.
Cash Flow
82
Very Positive
The company exhibits strong cash flow generation with consistent growth in free cash flow. The operating cash flow to net income ratio indicates efficient conversion of earnings into cash. However, the free cash flow to net income ratio, while solid, suggests room for further improvement in cash flow efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue875.46B885.82B762.61B734.10B670.33B558.26B
Gross Profit688.65B766.25B421.69B631.86B567.28B474.98B
EBITDA428.77B310.00B285.70B259.78B243.96B200.27B
Net Income206.78B202.10B181.38B168.64B164.51B125.45B
Balance Sheet
Total Assets1.23T1.23T1.20T1.03T992.84B853.29B
Cash, Cash Equivalents and Short-Term Investments533.64B538.53B525.16B426.27B426.63B338.79B
Total Debt39.24B37.28B29.24B24.58B21.60B20.75B
Total Liabilities258.76B262.65B241.36B213.72B203.78B180.88B
Stockholders Equity976.83B974.02B967.76B818.32B803.85B688.00B
Cash Flow
Free Cash Flow145.97B187.19B181.73B168.36B161.18B120.57B
Operating Cash Flow182.62B235.11B222.80B201.83B190.06B151.81B
Investing Cash Flow-27.97B-33.19B-35.81B-47.50B-29.30B-29.79B
Financing Cash Flow-142.95B-190.35B-110.89B-194.59B-106.72B-115.67B

HOYA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price153.29
Price Trends
50DMA
152.41
Positive
100DMA
143.38
Positive
200DMA
130.27
Positive
Market Momentum
MACD
-0.19
Negative
RSI
52.53
Neutral
STOCH
58.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Positive. The current price of 153.29 is above the 20-day moving average (MA) of 150.80, above the 50-day MA of 152.41, and above the 200-day MA of 130.27, indicating a bullish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 52.53 is Neutral, neither overbought nor oversold. The STOCH value of 58.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HOCPY.

HOYA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$194.04B71.7816.90%22.18%21.37%
76
Outperform
$36.84B25.8325.41%0.90%9.36%29.56%
69
Neutral
$16.68B30.2011.12%1.74%-25.29%
68
Neutral
$51.91B37.0620.74%0.84%9.79%9.53%
68
Neutral
$19.61B40.3716.94%0.32%4.90%-0.26%
67
Neutral
$57.34B34.546.54%2.08%8.23%-2.04%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HOCPY
HOYA
153.29
24.14
18.69%
BDX
Becton Dickinson
200.89
-21.85
-9.81%
HOLX
Hologic
75.00
2.56
3.53%
ISRG
Intuitive Surgical
542.32
0.33
0.06%
RMD
Resmed
252.27
13.38
5.60%
WST
West Pharmaceutical Services
267.56
-61.94
-18.80%

HOYA Corporate Events

Hoya Corp Reports Strong Quarterly Revenue Growth
Oct 31, 2025

Hoya Corporation is a diversified technology company operating primarily in the life care and information technology sectors, known for its high-value-added products such as eyeglass lenses and semiconductor mask blanks. In its latest earnings report, Hoya Corp announced a 9.2% increase in revenue for the quarter ending September 30, 2025, reaching 234,494 million yen, with a profit before tax rising by 14.5% to 71,930 million yen. The company’s performance was bolstered by strong sales in both its Life Care and Information Technology segments, with notable growth in eyeglass lenses and semiconductor-related products. The Life Care segment saw a 7.8% revenue increase, driven by robust sales in Europe and successful M&A activities, while the Information Technology segment experienced an 11.9% revenue boost due to high demand for advanced semiconductor products. Looking ahead, Hoya Corp remains optimistic about its growth prospects, focusing on expanding its market presence and enhancing product offerings across its business segments.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025